SpyGlass Ophthalmics snags $27.5m Series B

SpyGlass Ophthalmics, an ophthalmic therapeutics company, has secured $27.5 million in Series B financing.

SpyGlass Ophthalmics, an ophthalmic therapeutics company, has secured $27.5 million in Series B financing. The investors were Vensana Capital and New Enterprise Associates.

Source: Press Release